Bryce J. Laing, MD, David B. Ross, MD, Steven R

Slides:

Advertisements

Similar presentations

Of mice and men and surgical transcatheter aortic valve insertion

Advertisements

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

Stephen R. Broderick, MD, MPHS

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

A meta-analysis of comparative studies of endovascular versus open repair for blunt thoracic aortic injury Hisato Takagi, MD, PhD, Norikazu Kawai, MD,

Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant Victor van Berkel, MD, PhD

When is the Ross operation a good option to treat aortic valve disease? Tirone E. David, MD, Anna Woo, MD, Susan Armstrong, MSc, Manjula Maganti, MSc

Jennifer Chung, MD, MSc, Maral Ouzounian, MD, PhD

Building a bioartificial heart: A 3-song saga

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Abracadabra I, II…HeartMate 3?

Victor van Berkel, MD, PhD

William M. DeCampli, MD, PhD

How should we treat air leaks?

New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum Martin Czerny, MD, MBA The Journal.

Bicuspid aortic valve aortopathy: One size fits all?

The lord of the rings Antonio Miceli, MD, PhD

Is tissue the issue? Brian E. Louie, MD, MHA, MPH, FRCSC, FACS

Conduit conundrum: If not two, why three?

The variability of the mitral valve anatomy and terminology

Support Your Specialty

Innovation and science: The future of valve design

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Military surgeons just want to have fun

Do we need a bibliometrician to know which way the wind is blowing?

A first start for lung transplantation?

Stephen R. Broderick, MD, MPHS

Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

In search of the smoking gun in calcific aortic valve disease

Replicating the success of mitral valve repair in the aortic valve

Attachment disorder in thoracoabdominal surgery

The Ross procedure: Time to reevaluate the guidelines

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Patrick T. Roughneen, MD, Grant T. Fankhauser, MD, Abe DeAnda, MD

Functional tricuspid pathology: To treat or not to treat

Hans-Joachim Schäfers, MD

Concomitant replacement of the ascending aorta is free—for some

Innovation in cardiothoracic surgical training

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Tissue valve, nitinol stent, or storage solution

The future of cardiac surgery training: A survival guide

The continuing challenge of congenital heart disease in China

The Journal of Thoracic and Cardiovascular Surgery

Between a rock and a hard place

Ralph E. Delius, MD The Journal of Thoracic and Cardiovascular Surgery

Maral Ouzounian, MD, PhD, Amine Mazine, MD, MSc, Tirone E. David, MD

Vinay Badhwar, MD, John S. Ikonomidis, MD, PhD, Jeffrey P. Jacobs, MD

Therapeutic R2 resection for pleural mesothelioma

The Journal of Thoracic and Cardiovascular Surgery

“The more things change…”: The challenges ahead

Toward a more rational approach in treating type B aortic dissection

Evaluating the best approach to treatment of aortic stenosis: The jury is still out Glen B. Taksler, PhD The Journal of Thoracic and Cardiovascular Surgery

Proactive or reactive? Best approach to limb ischemia in peripheral venoarterial extracorporeal life support Matthew C. Black, MD, Mark S. Slaughter,

Preoperative PFTs: The answer is blowing in the wind

Of mice and men… The Journal of Thoracic and Cardiovascular Surgery

Did you like Terminator 3 better than Terminator 2

Samuel Kim, MD The Journal of Thoracic and Cardiovascular Surgery

Journal changes and initiatives

Descending thoracic and thoracoabdominal aortic aneurysms: “Busted”

Zone zero thoracic endovascular aortic repair is all about “location, location, location” Kevin L. Greason, MD The Journal of Thoracic and Cardiovascular.

Paul Philipp Heinisch, MD, Thierry Carrel, MD

Zipping up after a median sternotomy: Are we at the end of the wire?

Deciding how much to pay for effective care

Presentation transcript:

Glutaraldehyde treatment of allograft tissue decreases allosensitization after the Norwood procedure Bryce J. Laing, MD, David B. Ross, MD, Steven R. Meyer, MD, PhD, Patricia Campbell, MBChB, Anne M. Halpin, MSc, Lori J. West, MD, DPhil, Ivan M. Rebeyka, MD The Journal of Thoracic and Cardiovascular Surgery Volume 139, Issue 6, Pages 1402-1408 (June 2010) DOI: 10.1016/j.jtcvs.2009.12.034 Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Box-plot of PRA by group. The median, 25th, and 75th percentiles are shown. Outliers are expressed as separate dots outside the upper fence. PRA, Panel reactive antibody. The Journal of Thoracic and Cardiovascular Surgery 2010 139, 1402-1408DOI: (10.1016/j.jtcvs.2009.12.034) Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Immunohistochemistry of aortic allograft. A, Untreated aortic allograft stained for HLA-ABC. B, Glutaraldehyde-treated allograft stained for HLA-ABC. C, Untreated aortic allograft stained for HLA-DR. D, Glutaraldehyde-treated allograft stained for HLA-DR. Positive staining (arrows). The Journal of Thoracic and Cardiovascular Surgery 2010 139, 1402-1408DOI: (10.1016/j.jtcvs.2009.12.034) Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions